Vantage Consulting Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,254
Closed -$213K 203
2023
Q2
$213K Sell
2,254
-604
-21% -$51K 0.12% 186
2023
Q1
$216K Buy
2,858
+219
+8% +$16.5K 0.12% 198
2022
Q4
$203K Sell
2,639
-483
-15% -$36.7K 0.12% 194
2022
Q3
$208K Sell
3,122
-696
-18% -$44.1K 0.12% 179
2022
Q2
$200K Buy
3,818
+105
+3% +$5.97K 0.11% 197
2022
Q1
$211K Sell
3,713
-845
-19% -$45.3K 0.08% 198
2021
Q4
$235K Buy
+4,558
New +$224K 0.06% 195
2021
Q3
Sell
-4,302
Closed -$246K 208
2021
Q2
$246K Buy
+4,302
New +$251K 0.04% 129
2021
Q1
Sell
-2,196
Closed -$118K 333
2020
Q4
$118K Buy
+2,196
New +$114K 0.01% 129

Other funds holding CAH

Vantage Consulting Group's CAH Position: Q3 2023 in Review

Vantage Consulting Group sold out of Cardinal Health (CAH) in Q3 2023, closing a stake of 2,254 shares — an estimated $213K sold.

Vantage Consulting Group first reported a position in CAH in Q4 2020 and held it in 9 quarters. The position peaked at $246K in Q2 2021. 948 funds tracked by Wall St. Rank hold CAH as of Q3 2023.

  • Vantage Consulting Group reported no remaining Cardinal Health position as of Q3 2023 after selling out during the quarter.
  • Vantage Consulting Group sold 2,254 Cardinal Health shares in Q3 2023, an estimated $213K.
  • Vantage Consulting Group first reported a position in Cardinal Health in Q4 2020 and held it in 9 quarters.
  • Vantage Consulting Group's Cardinal Health position peaked at $246K in Q2 2021.
  • 948 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2023.

Based on Vantage Consulting Group's 13F filing for Q3 2023, filed 14 Nov 2023.